Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gian Maria Rossolini

Showing results (11-20 of 452) with videos related to

Pageof 46
Sort By:
Antimicrobial Agents and Chemotherapy|December 31, 2014
Tn6249, a new Tn6162 transposon derivative carrying a double-integron platform and involved with acquisition of the blaVIM-1 metallo-β-lactamase gene in Pseudomonas aeruginosaVincenzo Di Pilato, Simona Pollini, Gian Maria Rossolini
Journal of Global Antimicrobial Resistance|December 28, 2023
In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016-2020Gian Maria Rossolini, Francis F Arhin, Michal Kantecki
International Journal of Molecular Sciences|February 2, 2021
Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing PandemicFabio Arena, Simona Pollini, Gian Maria Rossolini, et al.
Frontiers in Molecular Biosciences|May 24, 2021
A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike ProteinMaria Luisa Di Vona, Gian Maria Rossolini, Marco Sette
Current Opinion in Microbiology|September 18, 2010
Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agentsGian Maria Rossolini, Elisabetta Mantengoli, Francesca Montagnani, et al.
Le Infezioni in Medicina|July 2, 2008
[Etiology, epidemiology and microbiological diagnosis of intra-abdominal infections]Giuseppe Nicoletti, Daria Nicolosi, Gian Maria Rossolini, et al.
Diagnostic Microbiology and Infectious Disease|August 22, 2021
Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-2018Gian Maria Rossolini, Marzena Bochenska, Laura Fumagalli, et al.
Current Opinion in Pharmacology|September 26, 2014
Update on the antibiotic resistance crisisGian Maria Rossolini, Fabio Arena, Patrizia Pecile, et al.
Expert Review of Anti-Infective Therapy|October 14, 2008
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implicationsLucia Pallecchi, Alessandro Bartoloni, Franco Paradisi, et al.
Expert Review of Anti-Infective Therapy|April 17, 2020
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combinationAndrea Novelli, Paola Del Giacomo, Gian Maria Rossolini, et al.
Pageof 46

Showing results (11-20 of 452) with videos related to

Sort By:
Pageof 46
Antimicrobial Agents and Chemotherapy|December 31, 2014
Tn6249, a new Tn6162 transposon derivative carrying a double-integron platform and involved with acquisition of the blaVIM-1 metallo-β-lactamase gene in Pseudomonas aeruginosaVincenzo Di Pilato, Simona Pollini, Gian Maria Rossolini
Journal of Global Antimicrobial Resistance|December 28, 2023
In vitro activity of aztreonam-avibactam and comparators against Metallo-β-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016-2020Gian Maria Rossolini, Francis F Arhin, Michal Kantecki
International Journal of Molecular Sciences|February 2, 2021
Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing PandemicFabio Arena, Simona Pollini, Gian Maria Rossolini, et al.
Frontiers in Molecular Biosciences|May 24, 2021
A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike ProteinMaria Luisa Di Vona, Gian Maria Rossolini, Marco Sette
Current Opinion in Microbiology|September 18, 2010
Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agentsGian Maria Rossolini, Elisabetta Mantengoli, Francesca Montagnani, et al.
Le Infezioni in Medicina|July 2, 2008
[Etiology, epidemiology and microbiological diagnosis of intra-abdominal infections]Giuseppe Nicoletti, Daria Nicolosi, Gian Maria Rossolini, et al.
Diagnostic Microbiology and Infectious Disease|August 22, 2021
Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-2018Gian Maria Rossolini, Marzena Bochenska, Laura Fumagalli, et al.
Current Opinion in Pharmacology|September 26, 2014
Update on the antibiotic resistance crisisGian Maria Rossolini, Fabio Arena, Patrizia Pecile, et al.
Expert Review of Anti-Infective Therapy|October 14, 2008
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implicationsLucia Pallecchi, Alessandro Bartoloni, Franco Paradisi, et al.
Expert Review of Anti-Infective Therapy|April 17, 2020
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combinationAndrea Novelli, Paola Del Giacomo, Gian Maria Rossolini, et al.
Pageof 46